Event Date/Time: Jun 26, 2008 End Date/Time: Jun 27, 2008
Registration Date: Jun 26, 2008
Early Registration Date: May 23, 2008
Report as Spam


The biosimilars market is on the verge of rapid expansion. Despite opposition from originator companies and delays by the US FDA, the European market continues to grow and biosimilars or "follow-on biologics" now represent one of the most evolving areas of product development in the biopharmaceutical industry.

This conference is the only event in Europe to cover the key regulatory, scientific and commercial issues facing companies working with biosimilars, enabling you to evaluate the vast opportunities available and barriers to overcome. Based on in-depth research and featuring an expert panel of speakers, this event - designed for originator as well as biosimilar companies - will allow you to successfully interpret the latest regulatory pathways in Europe, the current state of play in the US, and overcome issues pertaining to comparability, immunogenicity and clinical development. Don't get left behind in this constantly changing marketplace!

50% Discount for Academics and Start-up Biotech Companies - Please call Simon Lau for more details +44 (0)20 7017 7165 or email him on simon.lau@informa.com

Who Will Attend?Project Managers
Clinical Project Managers
Managing Directors
Business Development Manager
Regulatory Affairs Manager
Scientist Directors


Don't MissHear the latest regulatory developments in the EU and US and determine your best route to market approval
Overcome issues of comparability and immunogenicity for biosimilars and ensure the safety of your product
Accelerate the development of your biosimilar clinical trials and satisfy regulatory needs
Evaluate the commercial opportunities available for biosimilars and how to succeed in this very competitive market
Hear how biosimilars are being adopted in practice with unique insight from your key customers, the physicians and pharmacists

Key PresentationsMake the most of your time in Dublin by attending:

Pre-conference workshop - Overcoming the challenges of manufacturing biosimilars
Make the most of your stay in Dublin by attending this pre-conference workshop. Gain practical advice on how to manufacture biosimilars and meet the strict regulatory requirements. Key topics covered include: process development, analytical methods, outsourcing to CMOs, cost-of-goods and quality assessment.

Evening seminar on how to take a biosimilar to market (featuring dinner and refreshments) - IDEAL NETWORKING OPPORTUNITY
An ideal networking opportunity outside the confines of the conference, this informal yet informative evening seminar will take you through the key steps required to get a biosimilar to market. Led by industry experts James Harris of AS Biotech and former CEO of Genemedix, Paul Edwards. Dinner and refreshments provided.